Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

"Exploring the Potential Benefits of Using Dapagliflozin in Cirrhotic Chronic Liver Disease Patients- A Randomized Controlled Trial"

NCT07684326 is registered in ClinicalTrials.gov with Beni-Suef University as lead sponsor.

NCT NCT07684326
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07684326 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
"Exploring the Potential Benefits of Using Dapagliflozin in Cirrhotic Chronic Liver Disease Patients- A Randomized Controlled Trial"
Lead sponsor
Beni-Suef University
Phase
Phase 2/3
Overall status
Recruiting
Start date
July 31, 2026
Completion date
September 30, 2027
Enrollment
52 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ascites hepatic